(0.65%) 5 161.37 points
(0.30%) 38 791 points
(0.72%) 16 273 points
(0.26%) $78.31
(4.39%) $2.24
(1.03%) $2 332.40
(3.47%) $27.62
(0.07%) $965.95
(-0.08%) $0.928
(-0.43%) $10.83
(-0.17%) $0.796
(-0.13%) $91.33
-3.96% £ 24.25
Live Chart Being Loaded With Signals
Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases...
Stats | |
---|---|
Volumen de hoy | 4.26M |
Volumen promedio | 1.38M |
Capitalización de mercado | 24.63M |
EPS | £0 ( 2024-03-27 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.04 |
ATR14 | £0.358 (1.48%) |
Volumen Correlación
Sareum Holdings PLC Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sareum Holdings PLC Correlación - Moneda/Commodity
Sareum Holdings PLC Finanzas
Annual | 2022 |
Ingresos: | £0 |
Beneficio Bruto: | £-1 000.00 (0.00 %) |
EPS: | £-0.0469 |
FY | 2022 |
Ingresos: | £0 |
Beneficio Bruto: | £-1 000.00 (0.00 %) |
EPS: | £-0.0469 |
FY | 2022 |
Ingresos: | £0 |
Beneficio Bruto: | £0 (0.00 %) |
EPS: | £-0.0321 |
FY | 2021 |
Ingresos: | £0.00 |
Beneficio Bruto: | £0.00 (0.00 %) |
EPS: | £-0.0265 |
Financial Reports:
No articles found.
Sareum Holdings PLC
Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico